ProQR Therapeutics N.V(NASDAQ:PRQR) 
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It is primarily developing sepofarsen that is in phase II/III illuminate trial for treating leber's congenital amaurosis 10 disease; QR-421...
Website: http://www.proqr.com
Founded: 2012
Full Time Employees: 154
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.24
H 1.35
L 1.15
C 1.18
V 564,998
10EMA 1.18
20EMA 1.18
60EMA 1.18
120EMA 1.18
250EMA 1.18